falsefalse

Rapid Readouts: Five-Year Analysis of MURANO Study - Episode 1

5-Year Analysis of the MURANO Study for Relapsed/Refractory Chronic Lymphocytic Leukemia

December 23, 2020

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Now Playing: 5-Year Analysis of the MURANO Study for Relapsed/Refractory Chronic Lymphocytic Leukemia

    Now Playing
    EP. 1: 5-Year Analysis of the MURANO Study for Relapsed/Refractory Chronic Lymphocytic Leukemia
    EP. 1: 5-Year Analysis of the MURANO Study for Relapsed/Refractory Chronic Lymphocytic Leukemia

    Related Content:

    Rapid ReadoutsChronic Lymphocytic LeukemiaASH
    A First-in-Human, Phase 1a/b, Dose-Escalation/Expansion Study of BG-68501, a Selective CDK2 Inhibitor, as Monotherapy or in Combination With Fulvestrant for Patients With HR+/HER2– Breast Cancer and Other Advanced Solid Tumors: First Disclosure of Clinical Data
    ARCHES: 5-Year Follow-up Overall Survival (OS) Analysis of Enzalutamide (ENZA) Plus Androgen-Deprivation Therapy (ADT) in Patients (pts) With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    Event-free Survival (EFS) in MATTERHORN: A Randomized, Phase 3 Study of Durvalumab plus 5-Fluorouracil, Leucovorin, Oxaliplatin and Docetaxel Chemotherapy (FLOT) in Resectable Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
    x